These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6256650)

  • 1. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
    Darby G; Field HJ; Salisbury SA
    Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.
    Field HJ; Darby G; Wildy P
    J Gen Virol; 1980 Jul; 49(1):115-24. PubMed ID: 6252285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
    Palú G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
    Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.
    Kit S; Sheppard M; Ichimura H; Nusinoff-Lehrman S; Ellis MN; Fyfe JA; Otsuka H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1483-90. PubMed ID: 2829709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
    Collins P; Ellis MN
    J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus resistance to antiviral drugs.
    Morfin F; Thouvenot D
    J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutant.
    Larder BA; Darby G
    J Virol; 1982 May; 42(2):649-58. PubMed ID: 6283175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
    Furman PA; Coen DM; St Clair MH; Schaffer PA
    J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.
    Tanaka S; Toh Y; Mori R
    Arch Virol; 1993; 131(1-2):61-73. PubMed ID: 8392322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of resistance of herpes simplex virus to acyclovir.
    Crumpacker CS
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):190-5. PubMed ID: 2828441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
    Larder BA; Derse D; Cheng YC; Darby G
    J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
    Field HJ; Darby G
    Antimicrob Agents Chemother; 1980 Feb; 17(2):209-16. PubMed ID: 6247969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.